I believe the stats showed that 17% of those tested after dose 1 developed antibodies, not only 17 persons. It is a bit scary, as he said, yet others in the chat room shared their very high numbers of antibodies after dose 2.
I would have liked to have seen a breakdown by organ; also, each individual patient has a unique combination of meds. I'm wondering how deep the analysis will go with that. Will they create an algorithm to explore each med, each dosage, and each combination.
I appreciate their efforts as the clinical trials prior to vaccine distribution did not include us. This research is important.
Looking forward to seeing more. For now, even after bring vaccinated, I will continue with precautions.
Truth is, we are the ones who can teach others that none of us are going back to a past normal. The virus has changed us, just like our transplants have.